MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

1 year ago 24
Read Entire Article
  1. Homepage
  2. Finance
  3. MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

Related

Australia defends property tax changes designed to fix ‘broken’ housing

Australia defends property tax changes designed to fix ‘brok...

1 hour ago 1
Why China is positioned to capture the bulk of the economic robotic value

Why China is positioned to capture the bulk of the economic ...

2 hours ago 0
Japan and South Korea set a critical summit amid market volatility

Japan and South Korea set a critical summit amid market vola...

2 hours ago 0

Trending

1. scoringlive
2. pak vs ban
3. celestine subnautica 2
4. stephen kalyn
5. subnautica 2 roadmap
6. bts members
7. the boys season 5 episode 8
8. nick lachey
9. charlie evans
10. navy federal

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

1 year ago 732
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

1 year ago 594
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

1 year ago 460
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

1 year ago 458
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

1 year ago 407
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2026. All rights are reserved